Peking University Third Hospital’s Drug Clinical Trial Institution Attends the 2026 DIA Global Annual Meeting

Author: Gao Yuling

https://www.puh3.net.cn/info/1971/175671.htm

From May 13 to 16, 2026, the 2026 DIA Global Annual Meeting and Exhibition, hosted by the Drug Information Association, was held in Shanghai. Peking University Third Hospital was invited to attend and set up a booth.

Professor Li Haiyan, Director of our hospital’s Drug Clinical Trial Institution, was invited to deliver the opening remarks for the “ICH Outlook Session-ICH-E6R3 Special Topic” sub-forum, and also participated in roundtable discussions across multiple sub-forums. Xu Yan from the Drug Clinical Trial Institution gave an academic presentation at a sub-forum and participated in a roundtable discussion; Yang Zhenzhen and Wang Fangfang, head of the Institution’s Phase I research ward, each gave academic presentations at sub-forums.

During the DIA conference, the team also shared an overview of Peking University Third Hospital’s high-quality development, key discipline construction, and the research and development of innovative drugs and devices.

Group photo of Peking University Third Hospital attendees